Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rode

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Cancer|January 15, 1989
Detection of human probombesin mRNA in neuroendocrine (small cell) carcinoma of the lung. In situ hybridization with cRNA probeQ A Hamid, A E Bishop, D R Springall, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]M Haddad, N Nicolaiew, A Campeggi, et al.
Chemistry & Biodiversity|February 22, 2023
Design, Synthesis of 3-(5-Substituted Phenyl-[1,3,4]oxadiazol-2-yl)-1H-indole and Its Microbial ActivityManohar D Suryawanshi, Ganesh D Suryawanshi, Pravin C Mhaske, et al.
British Journal of Experimental Pathology|February 1, 1988
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodiesP O Wilson, P C Barber, Q A Hamid, et al.
Frontiers in Oncology|September 23, 2021
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Frontiers in Oncology|June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survivalLeonie K de Klerk, Anuj K Patel, Sarah Derks, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Physical Review Letters|March 24, 2023
Search for Dark-Matter-Nucleon Interactions via Migdal Effect with DarkSide-50P Agnes, I F M Albuquerque, T Alexander, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Cancer|January 15, 1989
Detection of human probombesin mRNA in neuroendocrine (small cell) carcinoma of the lung. In situ hybridization with cRNA probeQ A Hamid, A E Bishop, D R Springall, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]M Haddad, N Nicolaiew, A Campeggi, et al.
Chemistry & Biodiversity|February 22, 2023
Design, Synthesis of 3-(5-Substituted Phenyl-[1,3,4]oxadiazol-2-yl)-1H-indole and Its Microbial ActivityManohar D Suryawanshi, Ganesh D Suryawanshi, Pravin C Mhaske, et al.
British Journal of Experimental Pathology|February 1, 1988
The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodiesP O Wilson, P C Barber, Q A Hamid, et al.
Frontiers in Oncology|September 23, 2021
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Frontiers in Oncology|June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Oral Oncology|March 30, 2017
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J Hanna, Hongye Liu, Robert E Jones, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survivalLeonie K de Klerk, Anuj K Patel, Sarah Derks, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Physical Review Letters|March 24, 2023
Search for Dark-Matter-Nucleon Interactions via Migdal Effect with DarkSide-50P Agnes, I F M Albuquerque, T Alexander, et al.
Pageof 12